Description
Description
Indications
Letromina is indicated in treatment of breast cancer in postmenopausal women who have received 5 years of adjuvant tamoxifen therapy or as initial treatment of hormone receptor positive or hormone receptor unknown locally advanced or metastatic breast cancer
Presentation
Each carton contains 30 tablets of 2.5mg each.
